advertisement
Guthoff RF 9
Showing records 1 to 9 | Display all abstracts from Guthoff RF107948 Development of a Novel Valve-Controlled Drug-Elutable Microstent for Microinvasive Glaucoma Surgery: In Vitro and Preclinical In Vivo Studies
Siewert S
Translational vision science & technology 2023; 12: 4
107917 The Antibiotic Kitasamycin-A Potential Agent for Specific Fibrosis Preventing Therapy after Fistulating Glaucoma Surgery?
Sterenczak KA; Fuellen G
Pharmaceutics 2023; 15:
107948 Development of a Novel Valve-Controlled Drug-Elutable Microstent for Microinvasive Glaucoma Surgery: In Vitro and Preclinical In Vivo Studies
Kischkel S; Brietzke A
Translational vision science & technology 2023; 12: 4
107917 The Antibiotic Kitasamycin-A Potential Agent for Specific Fibrosis Preventing Therapy after Fistulating Glaucoma Surgery?
Jünemann A
Pharmaceutics 2023; 15:
107948 Development of a Novel Valve-Controlled Drug-Elutable Microstent for Microinvasive Glaucoma Surgery: In Vitro and Preclinical In Vivo Studies
Kinzel L
Translational vision science & technology 2023; 12: 4
107917 The Antibiotic Kitasamycin-A Potential Agent for Specific Fibrosis Preventing Therapy after Fistulating Glaucoma Surgery?
Guthoff RF
Pharmaceutics 2023; 15:
107948 Development of a Novel Valve-Controlled Drug-Elutable Microstent for Microinvasive Glaucoma Surgery: In Vitro and Preclinical In Vivo Studies
Lindner T
Translational vision science & technology 2023; 12: 4
107917 The Antibiotic Kitasamycin-A Potential Agent for Specific Fibrosis Preventing Therapy after Fistulating Glaucoma Surgery?
Stachs O; Stahnke T
Pharmaceutics 2023; 15:
107948 Development of a Novel Valve-Controlled Drug-Elutable Microstent for Microinvasive Glaucoma Surgery: In Vitro and Preclinical In Vivo Studies
Hinze U; Chichkov B; Schmidt W; Stiehm M; Grabow N; Guthoff RF; Schmitz KP; Stahnke T
Translational vision science & technology 2023; 12: 4